2010
DOI: 10.1016/j.freeradbiomed.2010.09.034
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of gene expression by α-tocopherol and α-tocopheryl phosphate in THP-1 monocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
89
0
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 49 publications
(93 citation statements)
references
References 79 publications
3
89
0
1
Order By: Relevance
“…In our model system, aTP increased angiogenesis in endothelial cells by increasing VEGF production by monocytes, and no direct proangiogenic or antiangiogenic effect on endothelial cells was observed during the time of the angiogenesis assay [70]. Induction of VEGF by aTP was the consequence of stimulation of the PI3K/Akt signaling pathway, a pathway that is prone to down-regulation by aT [71].…”
Section: Introductionmentioning
confidence: 74%
See 2 more Smart Citations
“…In our model system, aTP increased angiogenesis in endothelial cells by increasing VEGF production by monocytes, and no direct proangiogenic or antiangiogenic effect on endothelial cells was observed during the time of the angiogenesis assay [70]. Induction of VEGF by aTP was the consequence of stimulation of the PI3K/Akt signaling pathway, a pathway that is prone to down-regulation by aT [71].…”
Section: Introductionmentioning
confidence: 74%
“…Using THP-1 monocytes, we recently observed that the phosphorylated form of aT and aTP induced VEGF expression at the mRNA and protein level leading to increased in vitro angiogenesis in HUVEC, whereas aT was not effective [70] presumably as a consequence of a low ''aT kinase'' activity in these cells. In our model system, aTP increased angiogenesis in endothelial cells by increasing VEGF production by monocytes, and no direct proangiogenic or antiangiogenic effect on endothelial cells was observed during the time of the angiogenesis assay [70].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…As vitamin E is a potent antioxidant with anti-inflammatory properties, several lines www.intechopen.com of evidence suggest that -tocopherol has also potential beneficial effects with regard to cardiovascular disease (Singh et al, 2005;Rodrigo et al, 2008). A recent study has also demonstrated that natural vitamin E analog alpha-tocopheryl phosphate (alphaTP) modulates atherosclerotic and inflammatory events through the regulation of certain genes (Zingg et al, 2010). However, it is also important to point out that the non-antioxidant activities of tocopherols may also represent the main biological reason for the selective retention of alpha-tocopherol in the body, or vice versa, for the metabolic conversion and consequent elimination of the other tocopherols (Zingg et al, 2004).…”
Section: Vitamins With Antioxidant Properties: Vitamin E and Vitamin Cmentioning
confidence: 99%
“…In addition, aT and more so phosphorylated aT (aTP) stimulate PI3Kgamma (PI3Kg) activity by facilitating hTAP1-mediated PI exchange and presentation to the enzyme and/or by dissociation of an inactive heterodimer (5). Activation of the PI3Kg/protein kinase B (PKB) signal transduction pathway by aTP induces the expression of a number of genes such as the vascular endothelial growth factor (VEGF) which is important for angiogenesis, vasculogenesis and cell survival (6,7). Thus, vitamin E may act as active lipid mediator by liberating PI from hTAPs and making it accessible to phosphorylation by PI3Kg, a function that may be necessary for its essentiality as a vitamin.…”
mentioning
confidence: 99%